BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«PAP Smear Cervical Cancer

Below is an extended PAP Smear Cervical Cancer research listing. Click here to return to the PAP Smear Cervical Cancer main in depth entry.

Recent Publications on PAP Smear Cervical Cancer:

Decreasing cervical cancer mortality in Mexico: effect of papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
BACKGROUND: The reduction in cervical cancer mortality in developed...
Direct Link
10th October, 2008
Reproductive Health Divison, Center for Population Health Research,
Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999-2004.
BACKGROUND: Reports from limited geographic regions indicate higher rates...
Direct Link
10th October, 2008
Department of Public Health and Preventive Medicine, Oregon Health &
Pap smear findings in chronic renal failure patients compared with the normal population according to Bethesda 2001.
Dialysis remains the most common treatment for end-stage renal disease...
Direct Link
3rd October, 2008
Department of Pathology, Baskent University Medical School, Ankara,
Perceptions of cervical cancer threat, benefits, and barriers of Papanicolaou smear screening programs for women in Iran. 1st October, 2008
Department of Public Health, Hamadan University of Medical Sciences, Iran.
L1-peptides were more specific than VLPs for detecting HPV-infected females having cervical lesions, attending Engativa Hospital, Colombia.
A serological test for detecting HPV-infected females at risk of...
Direct Link
19th September, 2008
Fundation Instituto de Inmunologia de Colombia, Universidad Nacional de
[A falsely reassuring cervical smear in adenocarcinoma of the external os] 16th September, 2008
[A falsely reassuring cervical smear in adenocarcinoma of the external os] 16th September, 2008
Human papillomavirus testing for primary cervical cancer screening.
Cervical cancer is the second most common cancer in women worldwide and...
Direct Link
13th September, 2008
ECCA - European Cervical
[Adverse incidents in a cervical cancer screening programme] 13th September, 2008
Aarhus Universitet, Forskningsenheden for Almen Praksis, Regionshospitalet
Effectiveness of an organized cervical cancer screening program in Korea: Results from a cohort study.
Although the value of cervical cancer screening is widely acknowledged,...
Direct Link
12th September, 2008
National Cancer Control Research Institute, National Cancer Center,
No increased risk for cervical cancer after a broader definition of a negative Pap smear.
The definition of minimal relevant Pap smear abnormality is crucial for...
Direct Link
4th September, 2008
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Knowledge and general consideration about Pap test screening among women from Finland and Greece. 30th August, 2008
Lito Maternity Hospital, TEI University of Athens, Athens, Greece.
Comparative study between Pap smear cytology and FTIR spectroscopy: a new tool for screening for cervical cancer.
Aims: To evaluate Fourier transform infrared (FTIR) spectroscopy as new...
Direct Link
30th August, 2008
Departments of Pathology.
Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study. 22nd August, 2008
Instituto
Prevalence of High Grade Squamous Intraepithelial Lesion (HSIL) and Invasive Cervical Cancer in Patients with Low Grade Squamous Intraepithelial Lesion (LSIL) at Cervical Pap Smear. 21st August, 2008
Dept Obstetrics and Gynecology, Bangkok Metropolitan Administration
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional